Mouse Monoclonal TAU antibody. Suitable for ELISA, IHC-P, IHC-Fr and reacts with Human samples. Cited in 8 publications.
IgG1
Mouse
Preservative: 0.02% Sodium azide
Constituents: PBS, 6.97% L-Arginine
Liquid
Monoclonal
ELISA | IHC-P | IHC-Fr | |
---|---|---|---|
Human | Tested | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes GT-38 works as a capture antibody but we have not had success using it as a detection antibody and have not explored extensive antibody sandwich partner compatibility. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1 µg/mL | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Select an associated product type
Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed:21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed:21985311, PubMed:32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
MAPTL, MTBT1, TAU, MAPT, MTBT1, TAU, MAPTL, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau
Mouse Monoclonal TAU antibody. Suitable for ELISA, IHC-P, IHC-Fr and reacts with Human samples. Cited in 8 publications.
IgG1
Mouse
Preservative: 0.02% Sodium azide
Constituents: PBS, 6.97% L-Arginine
Liquid
Monoclonal
GT-38
Affinity purification Protein G
kappa
Blue Ice
1-2 weeks
+4°C
-20°C
Upon delivery aliquot
Avoid freeze / thaw cycle
Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.
If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.
Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com
This supplementary information is collated from multiple sources and compiled automatically.
Tau protein also known as MAPT (Microtubule-Associated Protein Tau) plays a mechanical role in stabilizing microtubules in neuronal axons. The human tau protein has several isoforms generally weighing between 45 to 65 kDa. Tau is predominantly expressed in neurons of the central nervous system but can also be found in some non-neuronal cells. In neurons tau binds to tubulin and facilitates the polymerization and stability of microtubules which are essential for maintaining cellular structure and transport functions.
Tau protein impacts the dynamics of the neuronal cytoskeleton. Tau is part of the intracellular transport system where it facilitates the movement of organelles and proteins along axons. This function is essential for neuron communication and resilience. Tau interacts with and regulates microtubule-associated complexes ensuring efficient intracellular transport. Its role in cytoskeletal integrity strongly influences cell signaling pathways critical for synaptic plasticity and neuronal survival.
Tau protein plays a significant part in cellular transport and signal transduction pathways. One key pathway is the MAPK signaling pathway where tau's phosphorylation state influences neuronal response to external stimuli. Additionally tau is involved in the PI3K/AKT pathway affecting cell growth and survival. Within these pathways tau's phosphorylation is regulated by kinases including GSK-3β and CDK5 while phosphatases like PP2A dephosphorylate tau to maintain its functional state.
Dysfunctional tau is strongly linked to neurodegenerative diseases particularly Alzheimer's disease (AD) and frontotemporal dementia (FTD). In AD hyperphosphorylated tau forms neurofibrillary tangles which disrupt neuronal function and promote cell death. This process often involves other proteins such as beta-amyloid which exacerbate tau's pathological aggregation. Understanding tauopathy mechanisms has guided the research and development of anti-tau antibodies like anti-GT3 and anti-conformation antibodies as therapeutic strategies against tau-related pathologies in neurodegenerative disorders.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
IHC image of Tau Alzheimer's Disease staining in a section of formalin-fixed paraffin-embedded human Alzheimer brain performed on a Leica BONDTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab246808, 1ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
GT-38 detects Alzheimer's disease (AD) tau pathology. Immunofluorescence staining with GT-38 (green) at 2 μg/mL followed by anti mouse-488 conjugated secondary detection antibody in 6 μm thick sections of paraffin embedded human AD hippocampus fixed in ethanol. Blue stain is DAPI positive nuclei.
GT-38 ELISA selectively detects AD-tau compared to tau monomer. GT-38 immobilized antibody selectively captures pathological tau derived from human AD brain tissue compared to recombinant tau monomer. GT-38 captured AD-tau antigens are detected with total tau rabbit polyclonal antibodies followed by HRP-conjugated anti-rabbit secondary and colorimetric readout. Total tau ELISA serves as a loading control demonstrating equivalent loading of total tau protein from both AD-tau and tau monomer.
Purified GT-38 mouse IgG1 antibody was coated on a 384 well plate at 450 ng/well (30 uL of 15 ng/uL) in 0.1 M NaHCO3 pH 9.6 at 4°C overnight. Plates were washed with PBST (phosphate buffered saline pH 7.2 with 0.05% Tween20) five times. GT-38 capture antibody was blocked with a commercial blocking solution 4°C overnight. Antigens consisted of either human brain derived insoluble tau enriched extract (AD-tau) or purified recombinant tau monomer. AD-tau was sonicated with a probe sonicator and antigens diluted in 0.2% BSA in PBS and applied to immobilized GT-38 and allowed to incubate 4°C overnight. Plates were washed with PBST five times. Rabbit polyclonal total tau detection antibody was diluted to 3.7 μg/mL in Buffer C (20 mM sodium phosphate pH 7.0, 2 mM EDTA, 400 mM sodium chloride, 1% BSA, 0.005% thimerosal), 30 μL was added to each well and incubated for 1 hour at room temperature. Plates were washed with PBST five times. Anti-rabbit HRP conjugated was diluted 1: 3,000 in Buffer C, 30 μL was added to each well and incubated for 1 hour at RT. Plates were washed with PBST five times. Colorimetric HRP substrate (30 μL/well) was added to the plate and developed at RT for 10 minutes. The reaction was quenched with addition of 30 μL/well 10% H2PO4 and the absorbance was measured at wavelength 450 nm.
IHC image of Tau Alzheimer's Disease staining in a section of formalin-fixed paraffin-embedded human normal brain performed on a Leica BONDTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab246808, 1ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
IHC image of Tau Alzheimer's Disease staining in a section of frozen human Alzheimer brain performed on a Leica BONDTM system using the standard protocol F. The section was incubated with ab246808, 1ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com